Value-based pricing and strategy

Develop pricing strategies that reflect the true value of your asset and gain insights to help you understand and quantify investment trade-offs.


Our expertise supports your pricing negations and includes:

  • Comprehensive assessments of the pricing and reimbursement landscape for your product through critical analysis of existing HTA and reimbursement decisions
  • Tailored research based on different endpoint scenarios to improve understanding of payer evidence requirements and support your value-based pricing and reimbursement strategy
  • Primary research through international advisory boards and interviews with payers and clinicians to understand real-world issues and decision-drivers.

It is critical to understand the scale and potential impact of high-cost and/or combination treatments coming to market, which can force significant changes in pricing and reimbursement policies; we can help you develop innovative pricing and contracting strategies to support the best outcomes for your asset.


Our consulting solutions include:

  • Evaluation of economically justifiable price
  • Payer pricing research
  • Innovative pricing and contracting strategy
  • Lifecycle management pricing strategy


These services are provided by Avalere, PAI, PRMA Consulting, and Skysis – part of Fishawack Health.

Request a call

Many thanks for supporting our launch. I really appreciate your flexibility with timing and study design to give us impactful and actionable next steps for our payer customers. We couldn’t have done it without your support. Job well done!

Payer Access Marketing Manager, top-5 pharmaceutical company.

You have a vision; we are the consulting partner that will get you there.
We would be delighted to have a confidential conversation about your market access needs.